hemotherapy

Augusts 12, 2024

The Hematology Research Group at HCU Lozano Blesa performs the first apheresis for CART therapy in Aragon

The IIS Aragón research group has been accredited for this process, the first part of these innovative therapies. CART therapy is increasingly being established as a treatment for hematological tumors, mainly lymphomas.